Evaluation of clarity of the STOPP/START criteria for clinical applicability in prescribing for older people: a quality appraisal study

Objectives Appropriate prescribing in older people continues to be challenging. Studies still report a high prevalence of inappropriate prescribing in older people. To reduce the problem of underprescribing and overprescribing in this population, explicit drug optimisation tools like Screening Tool...

Full description

Saved in:
Bibliographic Details
Main Authors: Corlina Johanna Alida Huibers, Wilma Knol, Bastiaan Theodoor Gerard Marie Sallevelt, Eugene van Puijenbroek, Toine Egberts, Ingeborg Wilting
Format: Article
Language:English
Published: BMJ Publishing Group 2020-02-01
Series:BMJ Open
Online Access:https://bmjopen.bmj.com/content/10/2/e033721.full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832574375119814656
author Corlina Johanna Alida Huibers
Wilma Knol
Bastiaan Theodoor Gerard Marie Sallevelt
Eugene van Puijenbroek
Toine Egberts
Ingeborg Wilting
author_facet Corlina Johanna Alida Huibers
Wilma Knol
Bastiaan Theodoor Gerard Marie Sallevelt
Eugene van Puijenbroek
Toine Egberts
Ingeborg Wilting
author_sort Corlina Johanna Alida Huibers
collection DOAJ
description Objectives Appropriate prescribing in older people continues to be challenging. Studies still report a high prevalence of inappropriate prescribing in older people. To reduce the problem of underprescribing and overprescribing in this population, explicit drug optimisation tools like Screening Tool of Older Persons’ potentially inappropriate Prescriptions/Screening Tool to Alert to Right Treatment (STOPP/START) have been developed. The aim of this study was to evaluate the clinical applicability of STOPP/START criteria in daily patient care by assessing the clarity of singular criteria.Design Quality appraisal study.Methods For each of the 114 STOPP/START criteria V.2, elements describing the action (what/how to do), condition (when to do) and explanation (why to do) were identified. Next, the clarity of these three elements was quantified on a 7-point Likert scale using tools provided by the Appraisal of Guidelines for Research and Evaluation (AGREE) Consortium.Primary and secondary outcomes The primary outcome measure was the clarity rating per element, categorised into high (>67.7%), moderate (33.3%–67.7%) or low (<33.3%). Secondary, factors that positively or negatively affected clarity most were identified. Additionally, the nature of the conditions was further classified into five descriptive components: disease, sign, symptom, laboratory finding and medication.Results STOPP recommendations had an average clarity rating of 64%, 60% and 69% for actions, conditions and explanations, respectively. The average clarity rating in START recommendations was 60% and 57% for actions and conditions, respectively. There were no statements present to substantiate the prescription of potential omissions for the 34 START criteria.Conclusions Our results show that the clarity of the STOPP/START criteria can be improved. For future development of explicit drug optimisation tools, such as STOPP/START, our findings identified facilitators (high clarity) and barriers (low clarity) that can be used to improve the clarity of clinical practice guidelines on a language level and therefore enhance clinical applicability.
format Article
id doaj-art-722485d9c8054021989356e7a90d3523
institution Kabale University
issn 2044-6055
language English
publishDate 2020-02-01
publisher BMJ Publishing Group
record_format Article
series BMJ Open
spelling doaj-art-722485d9c8054021989356e7a90d35232025-02-01T16:15:09ZengBMJ Publishing GroupBMJ Open2044-60552020-02-0110210.1136/bmjopen-2019-033721Evaluation of clarity of the STOPP/START criteria for clinical applicability in prescribing for older people: a quality appraisal studyCorlina Johanna Alida Huibers0Wilma Knol1Bastiaan Theodoor Gerard Marie Sallevelt2Eugene van Puijenbroek3Toine Egberts4Ingeborg Wilting52 Geriatrics, Department of Geriatric Medicine, University Medical Center Utrecht, Utrecht University, Utrecht, The NetherlandsDepartment of Geriatric Medicine, Utrecht University, Utrecht, The Netherlands1 Clinical Pharmacy, University Medical Center Utrecht, Utrecht, Utrecht, The Netherlands1Netherlands Pharmacovigilance Centre Lareb, ‘s-Hertogenbosch, Netherlands1 Clinical Pharmacy, University Medical Center Utrecht, Utrecht, Utrecht, The Netherlandsclinical pharmacistObjectives Appropriate prescribing in older people continues to be challenging. Studies still report a high prevalence of inappropriate prescribing in older people. To reduce the problem of underprescribing and overprescribing in this population, explicit drug optimisation tools like Screening Tool of Older Persons’ potentially inappropriate Prescriptions/Screening Tool to Alert to Right Treatment (STOPP/START) have been developed. The aim of this study was to evaluate the clinical applicability of STOPP/START criteria in daily patient care by assessing the clarity of singular criteria.Design Quality appraisal study.Methods For each of the 114 STOPP/START criteria V.2, elements describing the action (what/how to do), condition (when to do) and explanation (why to do) were identified. Next, the clarity of these three elements was quantified on a 7-point Likert scale using tools provided by the Appraisal of Guidelines for Research and Evaluation (AGREE) Consortium.Primary and secondary outcomes The primary outcome measure was the clarity rating per element, categorised into high (>67.7%), moderate (33.3%–67.7%) or low (<33.3%). Secondary, factors that positively or negatively affected clarity most were identified. Additionally, the nature of the conditions was further classified into five descriptive components: disease, sign, symptom, laboratory finding and medication.Results STOPP recommendations had an average clarity rating of 64%, 60% and 69% for actions, conditions and explanations, respectively. The average clarity rating in START recommendations was 60% and 57% for actions and conditions, respectively. There were no statements present to substantiate the prescription of potential omissions for the 34 START criteria.Conclusions Our results show that the clarity of the STOPP/START criteria can be improved. For future development of explicit drug optimisation tools, such as STOPP/START, our findings identified facilitators (high clarity) and barriers (low clarity) that can be used to improve the clarity of clinical practice guidelines on a language level and therefore enhance clinical applicability.https://bmjopen.bmj.com/content/10/2/e033721.full
spellingShingle Corlina Johanna Alida Huibers
Wilma Knol
Bastiaan Theodoor Gerard Marie Sallevelt
Eugene van Puijenbroek
Toine Egberts
Ingeborg Wilting
Evaluation of clarity of the STOPP/START criteria for clinical applicability in prescribing for older people: a quality appraisal study
BMJ Open
title Evaluation of clarity of the STOPP/START criteria for clinical applicability in prescribing for older people: a quality appraisal study
title_full Evaluation of clarity of the STOPP/START criteria for clinical applicability in prescribing for older people: a quality appraisal study
title_fullStr Evaluation of clarity of the STOPP/START criteria for clinical applicability in prescribing for older people: a quality appraisal study
title_full_unstemmed Evaluation of clarity of the STOPP/START criteria for clinical applicability in prescribing for older people: a quality appraisal study
title_short Evaluation of clarity of the STOPP/START criteria for clinical applicability in prescribing for older people: a quality appraisal study
title_sort evaluation of clarity of the stopp start criteria for clinical applicability in prescribing for older people a quality appraisal study
url https://bmjopen.bmj.com/content/10/2/e033721.full
work_keys_str_mv AT corlinajohannaalidahuibers evaluationofclarityofthestoppstartcriteriaforclinicalapplicabilityinprescribingforolderpeopleaqualityappraisalstudy
AT wilmaknol evaluationofclarityofthestoppstartcriteriaforclinicalapplicabilityinprescribingforolderpeopleaqualityappraisalstudy
AT bastiaantheodoorgerardmariesallevelt evaluationofclarityofthestoppstartcriteriaforclinicalapplicabilityinprescribingforolderpeopleaqualityappraisalstudy
AT eugenevanpuijenbroek evaluationofclarityofthestoppstartcriteriaforclinicalapplicabilityinprescribingforolderpeopleaqualityappraisalstudy
AT toineegberts evaluationofclarityofthestoppstartcriteriaforclinicalapplicabilityinprescribingforolderpeopleaqualityappraisalstudy
AT ingeborgwilting evaluationofclarityofthestoppstartcriteriaforclinicalapplicabilityinprescribingforolderpeopleaqualityappraisalstudy